Psychotic Disorders - Mexico | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$102.80m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.31%, resulting in a market volume of US$101.20m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$62.53 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Mexico is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trend.Customer preferences in Mexico are shifting towards a greater focus on mental health and well-being. As awareness and understanding of psychotic disorders increase, there is a growing demand for effective treatments and therapies. Customers are seeking innovative solutions that can help manage symptoms and improve quality of life. This shift in preferences is driving the growth of the Psychotic Disorders market in Mexico.Trends in the market are also playing a crucial role in its development. Advances in medical research and technology have led to the development of new and more effective treatments for psychotic disorders. Pharmaceutical companies are investing heavily in research and development to bring these innovative therapies to the market. This has resulted in a wider range of treatment options available to patients in Mexico, leading to increased demand and market growth.Local special circumstances in Mexico are contributing to the development of the Psychotic Disorders market. The Mexican government has recognized the importance of mental health and has implemented policies and initiatives to improve access to mental healthcare. This includes increasing funding for mental health services and promoting awareness and education about psychotic disorders. These efforts have not only increased the availability of treatment options but have also reduced the stigma associated with mental health, encouraging more individuals to seek help and driving market growth.Underlying macroeconomic factors are also playing a role in the development of the Psychotic Disorders market in Mexico. The country's growing population and increasing urbanization are leading to higher levels of stress and mental health issues. Additionally, rising disposable incomes and improved healthcare infrastructure are making mental healthcare more accessible to a larger portion of the population. These factors are driving the demand for treatments and therapies for psychotic disorders, contributing to the growth of the market.In conclusion, the Psychotic Disorders market in Mexico is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trend. As awareness and understanding of psychotic disorders increase and new treatments become available, the market is expected to continue growing in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.